Envoy Medical, Inc. (COCH)
NASDAQ: COCH · Real-Time Price · USD
1.510
+0.040 (2.72%)
Aug 13, 2025, 4:00 PM - Market closed
Envoy Medical Stock Forecast
Stock Price Forecast
According to 2 professional analysts, the 12-month price target for Envoy Medical stock ranges from a low of $9.00 to a high of $9.50. The average analyst price target of $9.25 forecasts a 512.58% increase in the stock price over the next year.
Price Target: $9.25 (+512.58%)
Analyst Consensus: Strong Buy
* Price targets were last updated on May 27, 2025.
Analyst Ratings
The average analyst rating for Envoy Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $9.25 → $9.5 | Strong Buy | Maintains | $9.25 → $9.5 | +529.14% | May 27, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $9 → $9.25 | Strong Buy | Maintains | $9 → $9.25 | +512.58% | Apr 21, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $8.75 → $9 | Strong Buy | Maintains | $8.75 → $9 | +496.03% | Dec 6, 2024 |
| Brookline Capital | Brookline Capital | Strong Buy Initiates $9 | Strong Buy | Initiates | $9 | +496.03% | Oct 14, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $8.5 → $8.75 | Strong Buy | Maintains | $8.5 → $8.75 | +479.47% | Sep 3, 2024 |
Financial Forecast
Revenue This Year
238.34K
from 225.00K
Increased by 5.93%
Revenue Next Year
280.50K
from 238.34K
Increased by 17.69%
EPS This Year
-1.30
from -1.49
EPS Next Year
-1.39
from -1.30
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 315,000 | 420,000 |
| Avg | 238,343 | 280,500 |
| Low | 182,280 | 196,000 |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | 40.0% | 76.2% |
| Avg | 5.9% | 17.7% |
| Low | -19.0% | -17.8% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | -1.26 | -1.24 |
| Avg | -1.30 | -1.39 |
| Low | -1.38 | -1.64 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.